{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:33:16Z","timestamp":1791369196974,"version":"4.3.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cmi.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:16:13Z","timestamp":1706274973000},"page":"601-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Li","family":"Biyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yahui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuanfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Xifeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.01.005_bib1","first-page":"92","article-title":"Chinese expert consensus for invasive fungal disease in patients after hematopoietic stem cell transplantation (2023)","volume":"44","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.cmi.2024.01.005_bib2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/cncr.21755","article-title":"Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer\/Mycosis Study Group (EORTC\/MSG) criteria be revised?","volume":"106","author":"Hachem","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2024.01.005_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cmi.2024.01.005_bib5","article-title":"Antifungal Therapy in hematopoietic stem cell transplant recipients. mediterr","volume":"8","author":"Busca","year":"2016","journal-title":"J\u00a0Hematol Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12879-022-07298-2","article-title":"Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.cmi.2024.01.005_bib8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cmi.2024.01.005_bib12","doi-asserted-by":"crossref","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.01.005_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/tid.12328","article-title":"Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients","volume":"17","author":"Atalla","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.bbmt.2016.06.008","article-title":"Risk factors for invasive mold infections and implications for choice of prophylaxis after allogeneic stem cell transplantation","volume":"22","author":"Blennow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib15","doi-asserted-by":"crossref","first-page":"805514","DOI":"10.3389\/fcimb.2021.805514","article-title":"Management of invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation: the turin experience","volume":"11","author":"Busca","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2024.01.005_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciy150","volume":"67","author":"Cesaro","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jmii.2018.09.006","article-title":"Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Chien","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2024.01.005_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.bbmt.2017.06.012","article-title":"Epidemiology and risk factors for invasive fungal diseases among allogeneic hematopoietic stem cell transplant recipients in Korea: results of \u201cRISK\u201d study","volume":"23","author":"Choi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib19","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1080\/10428194.2018.1553303","article-title":"Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation","volume":"60","author":"Christen","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cmi.2024.01.005_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/myc.12318","article-title":"Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens","volume":"58","author":"Corzo-Le\u00f3n","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.01.005_bib21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","article-title":"Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2024.01.005_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-016-0305-y","article-title":"Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study","volume":"9","author":"Gao","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cmi.2024.01.005_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bmt.2008.303","article-title":"Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT","volume":"43","author":"Gil","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12879-015-1329-6","article-title":"Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study","volume":"15","author":"Harrison","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/mmy\/myy015","article-title":"Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish pediatric bone marrow transplantation study group","volume":"57","author":"Hazar","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2024.01.005_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2334-12-44","article-title":"Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit","volume":"12","author":"Hung","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib31","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00277-021-04660-3","volume":"100","author":"Kimura","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2024.01.005_bib32","doi-asserted-by":"crossref","first-page":"209.e1","DOI":"10.1016\/j.jtct.2021.12.020","article-title":"Risk and predictive factors for Candidemia after allogeneic hematopoietic cell transplantation: JSTCT transplant complications working group","volume":"28","author":"Kimura","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2024.01.005_bib33","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bbmt.2007.06.013","article-title":"High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation","volume":"13","author":"Labb\u00e9","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/00365548.2011.623311","article-title":"Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients","volume":"44","author":"Li","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib35","doi-asserted-by":"crossref","first-page":"508.e1","DOI":"10.1016\/j.jtct.2022.04.023","article-title":"Invasive yeast infection after haploidentical donor hematopoietic cell transplantation associated with cytokine release syndrome","volume":"28","author":"Little","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2024.01.005_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmii.2015.01.002","article-title":"Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2024.01.005_bib37","first-page":"1735","article-title":"Clinical characteristics and risk factors of invasive fungal disease after hematopoietic stem cell transplantation: report of 233 cases","volume":"42","author":"Ma","year":"2020","journal-title":"J Army Med Univ"},{"key":"10.1016\/j.cmi.2024.01.005_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2024.01.005_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2009.78","article-title":"Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT","volume":"44","author":"Martino","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib40","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00277-021-04569-x","article-title":"Rifaximin use favoured micafungin-resistant Candida spp. Infections in recipients of allogeneic hematopoietic cell transplantation","volume":"100","author":"Marzuttini","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2024.01.005_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-3062.2007.00272.x","article-title":"Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation","volume":"10","author":"Mihu","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","article-title":"Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients","volume":"44","author":"Mikulska","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2007.02.012","article-title":"Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases","volume":"13","author":"Miyakoshi","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2015.181","article-title":"Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis","volume":"50","author":"Montesinos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(94)90088-4","article-title":"Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome","volume":"96","author":"Morrison","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.01.005_bib46","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","article-title":"Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience","volume":"19","author":"Omer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib47","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bmt.2009.383","article-title":"Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload","volume":"45","author":"Ozyilmaz","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/bmt.2014.229","article-title":"Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time","volume":"50","author":"Parody","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1399-3062.2007.00219.x","article-title":"Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients","volume":"9","author":"Post","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/bmt.2015.318","article-title":"Erratum: risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis","volume":"51","author":"Riches","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbmt.2018.09.028","article-title":"Mainly post-transplant factors are associated with invasive aspergillosis after allogeneic stem cell transplantation: a study from the surveillance des aspergilloses invasives en France and Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"25","author":"Robin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib52","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbmt.2009.08.006","article-title":"Incidence of viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients","volume":"15","author":"Satwani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib53","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1631\/jzus.B1500005","article-title":"Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years","volume":"16","author":"Shi","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.cmi.2024.01.005_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2012.08.012","article-title":"Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Srinivasan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5603\/AHP.a2021.0025","article-title":"High risk of invasive fungal disease in children undergoing hematopoietic cell transplantation or complex anticancer therapy: adverse role of post-transplant CMV replication","volume":"52","author":"Styczy\u0144ski","year":"2021","journal-title":"Acta Haematol Pol"},{"key":"10.1016\/j.cmi.2024.01.005_bib56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/1469-0691.12120","article-title":"Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation","volume":"19","author":"Sun","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.01.005_bib57","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1704543","article-title":"Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation","volume":"34","author":"Thursky","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"van Burik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib60","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib61","first-page":"486","article-title":"The prevalence and risk factors of invasive fungal infection in hematopoietic stem cell transplant recipients","volume":"46","author":"Xu","year":"2007","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.cmi.2024.01.005_bib62","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2017.07.025","article-title":"Cytomegalovirus reactivation is associated with increased risk of late-onset invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a multicenter study in the current era of viral load monitoring","volume":"23","author":"Yong","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2024.01.005_bib63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3062.2010.00497.x","article-title":"Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience","volume":"12","author":"Zhang","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib64","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0924-8579(08)70012-8","article-title":"Risk factors for invasive fungal infections in haematopoietic stem cell transplantation","volume":"32","author":"Camps","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2024.01.005_bib65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-100-3-345","article-title":"Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia","volume":"100","author":"Gerson","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.01.005_bib66","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.4049\/jimmunol.178.10.6367","article-title":"Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion","volume":"178","author":"Zarember","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2024.01.005_bib67","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1128\/IAI.00909-06","article-title":"Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia","volume":"74","author":"Bonnett","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2024.01.005_bib68","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2024.01.005_bib69","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/iai.61.11.4870-4877.1993","article-title":"Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon","volume":"61","author":"Roilides","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2024.01.005_bib70","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/iai.65.2.564-570.1997","article-title":"Th1 and Th2 cytokines in mice with invasive aspergillosis","volume":"65","author":"Cenci","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2024.01.005_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110550","article-title":"Immune defence to invasive fungal infections: a comprehensive review","volume":"130","author":"Pathakumari","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cmi.2024.01.005_bib72","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/blood.2022015474","article-title":"GARP-mediated active TGF-\u03b21 induces bone marrow NK cell dysfunction in AML patients with early relapse post-allo-HSCT","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2024.01.005_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/iai.51.2.547-555.1986","article-title":"Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells","volume":"51","author":"Hidore","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2024.01.005_bib74","first-page":"428","article-title":"Mechanistic basis of super-infection: influenza-associated invasive pulmonary aspergillosis","volume":"8","author":"Robinson","year":"2022","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.cmi.2024.01.005_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2024.01.005_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QCO.0000000000000502","article-title":"Invasive fungal disease and cytomegalovirus infection: is there an association?","volume":"31","author":"Yong","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.005_bib77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cmi.2021.10.008","article-title":"The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"28","author":"Chuleerarux","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.01.005_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1054\/blre.2000.0137","article-title":"Management of graft-versus-host disease","volume":"14","author":"Arai","year":"2000","journal-title":"Blood Rev"},{"key":"10.1016\/j.cmi.2024.01.005_bib79","first-page":"1058","article-title":"Invasive fungal infections and targeted therapies in hematological malignancies","volume":"7","author":"Little","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.cmi.2024.01.005_bib80","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2024.01.005_bib81","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","article-title":"Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors","volume":"344","author":"Laughlin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.01.005_bib82","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources","volume":"342","author":"Rocha","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.01.005_bib83","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17652","article-title":"Comparison of antifungal prophylaxis drugs in patients with hematological disease or undergoing hematopoietic stem cell transplantation: a systematic review and network meta-analysis","volume":"3","author":"Wang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.01.005_bib84","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:51:02Z","timestamp":1746103862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1198743X24000247"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.005","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}